Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Stem Cell Research

Free Subscription Articles published in Oncogene Retrieve available abstracts of 79 articles: HTML format

Single Articles

July 2022
1. BALINTH S, Fisher ML, Hwangbo Y, Wu C, et al
   EZH2 regulates a SETDB1/DeltaNp63alpha axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma.
   Oncogene. 2022 Jul 21. pii: 10.1038/s41388-022-02417.
   PubMed     Abstract available
   
   
   June 2022
2. BUSCHHAUS JM, Rajendran S, Humphries BA, Cutter AC, et al
   Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer.
   Oncogene. 2022 Jun 22. pii: 10.1038/s41388-022-02385.
   PubMed     Abstract available
   
   
   May 2022
3. LORENZO-MARTIN LF, Menacho-Marquez M, Fernandez-Parejo N, Rodriguez-Fdez S, et al
   The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function.
   Oncogene. 2022 May 9. pii: 10.1038/s41388-022-02341.
   PubMed     Abstract available
   
   
   April 2022
4. KUDARAVALLI S, den Hollander P, Mani SA
   Role of p38 MAP kinase in cancer stem cells and metastasis.
   Oncogene. 2022 Apr 30. pii: 10.1038/s41388-022-02329.
   PubMed     Abstract available
   
   
   
5. LANE R, Cilibrasi C, Chen J, Shah K, et al
   PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38(MAPK) signalling.
   Oncogene. 2022 Apr 7. pii: 10.1038/s41388-022-02294.
   PubMed     Abstract available
   
   
   March 2022
6. YANG YS, Jia XZ, Lu QY, Cai SL, et al
   Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells.
   Oncogene. 2022 Mar 29. pii: 10.1038/s41388-022-02278.
   PubMed     Abstract available
   
   
   
7. SONG H, Wang J, Wang X, Yuan B, et al
   HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation.
   Oncogene. 2022 Mar 22. pii: 10.1038/s41388-022-02271.
   PubMed     Abstract available
   
   
   
8. LEE WK, Zhu X, Park S, Zhu YJ, et al
   Regulation of cancer stem cell activity by thyroid hormone receptor beta.
   Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02242.
   PubMed     Abstract available
   
   
   
9. WU WR, Shi XD, Zhang FP, Zhu K, et al
   Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
   Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02246.
   PubMed     Abstract available
   
   
   
10. ZHANG T, Wang Y, Li Q, Lin L, et al
    Mesenchymal stromal cells equipped by IFNalpha empower T cells with potent anti-tumor immunity.
    Oncogene. 2022;41:1866-1881.
    PubMed     Abstract available
    
    
    February 2022
11. TURDO A, Gaggianesi M, Di Franco S, Veschi V, et al
    Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51.
    Oncogene. 2022 Feb 25. pii: 10.1038/s41388-022-02239.
    PubMed     Abstract available
    
    
    
12. YUAN S, Zhang P, Wen L, Jia S, et al
    Correction: miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma.
    Oncogene. 2022 Feb 4. pii: 10.1038/s41388-022-02188.
    PubMed    
    
    
    January 2022
13. ZOU H, Luo J, Guo Y, Liu Y, et al
    RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7.
    Oncogene. 2022 Jan 31. pii: 10.1038/s41388-022-02198.
    PubMed     Abstract available
    
    
    
14. FU L, Fan J, Maity S, McFadden G, et al
    PD-L1 interacts with Frizzled 6 to activate beta-catenin and form a positive feedback loop to promote cancer stem cell expansion.
    Oncogene. 2022 Jan 17. pii: 10.1038/s41388-021-02144.
    PubMed     Abstract available
    
    
    
15. CHEN J, Hou SF, Tang FJ, Liu DS, et al
    HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma.
    Oncogene. 2022;41:99-111.
    PubMed     Abstract available
    
    
    
16. LEON F, Seshacharyulu P, Nimmakayala RK, Chugh S, et al
    Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer.
    Oncogene. 2022;41:57-71.
    PubMed     Abstract available
    
    
    November 2021
17. CHEN Y, Zhao H, Liang W, Jiang E, et al
    Autophagy regulates the cancer stem cell phenotype of head and neck squamous cell carcinoma through the noncanonical FOXO3/SOX2 axis.
    Oncogene. 2021 Nov 19. pii: 10.1038/s41388-021-02115.
    PubMed     Abstract available
    
    
    October 2021
18. GAO S, Soares F, Wang S, Wong CC, et al
    CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer.
    Oncogene. 2021 Oct 7. pii: 10.1038/s41388-021-01882.
    PubMed     Abstract available
    
    
    September 2021
19. FENG Q, Li S, Ma HM, Yang WT, et al
    LGR6 activates the Wnt/beta-catenin signaling pathway and forms a beta-catenin/TCF7L2/LGR6 feedback loop in LGR6(high) cervical cancer stem cells.
    Oncogene. 2021 Sep 6. pii: 10.1038/s41388-021-02002.
    PubMed     Abstract available
    
    
    August 2021
20. ZHANG F, Li P, Liu S, Yang M, et al
    beta-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells.
    Oncogene. 2021 Aug 3. pii: 10.1038/s41388-021-01986.
    PubMed     Abstract available
    
    
    
21. YUAN S, Zhang P, Wen L, Jia S, et al
    miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma.
    Oncogene. 2021 Aug 3. pii: 10.1038/s41388-021-01973.
    PubMed     Abstract available
    
    
    
22. YAN Y, Narayan A, Cho S, Cheng Z, et al
    CRYbetaB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer.
    Oncogene. 2021 Aug 2. pii: 10.1038/s41388-021-01975.
    PubMed     Abstract available
    
    
    
23. PAL A, Barrett TF, Paolini R, Parikh A, et al
    Partial EMT in head and neck cancer biology: a spectrum instead of a switch.
    Oncogene. 2021;40:5049-5065.
    PubMed     Abstract available
    
    
    
24. MELOCCHI V, Dama E, Mazzarelli F, Cuttano R, et al
    Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.
    Oncogene. 2021;40:4980-4991.
    PubMed     Abstract available
    
    
    
25. BAUER J, Cuvelier N, Ragab N, Simon-Keller K, et al
    Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoforms.
    Oncogene. 2021;40:4955-4966.
    PubMed     Abstract available
    
    
    July 2021
26. LI Y, Fei H, Lin Q, Liang F, et al
    ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
    Oncogene. 2021 Jul 1. pii: 10.1038/s41388-021-01913.
    PubMed     Abstract available
    
    
    June 2021
27. VANOLI F, Meskauskaite B, Herviou L, Mallen W, et al
    Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors.
    Oncogene. 2021 Jun 30. pii: 10.1038/s41388-021-01843.
    PubMed     Abstract available
    
    
    
28. CHEN T, Zhang F, Liu J, Huang Z, et al
    Dual role of WNT5A in promoting endothelial differentiation of glioma stem cells and angiogenesis of glioma derived endothelial cells.
    Oncogene. 2021 Jun 29. pii: 10.1038/s41388-021-01922.
    PubMed     Abstract available
    
    
    
29. HAGIWARA M, Fushimi A, Yamashita N, Bhattacharya A, et al
    MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells.
    Oncogene. 2021 Jun 23. pii: 10.1038/s41388-021-01899.
    PubMed     Abstract available
    
    
    
30. ZHANG J, Guan W, Xu X, Wang F, et al
    A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.
    Oncogene. 2021 Jun 23. pii: 10.1038/s41388-021-01891.
    PubMed     Abstract available
    
    
    
31. MCANDREWS KM, Vazquez-Arreguin K, Kwak C, Sugimoto H, et al
    alphaSMA(+) fibroblasts suppress Lgr5(+) cancer stem cells and restrain colorectal cancer progression.
    Oncogene. 2021 Jun 9. pii: 10.1038/s41388-021-01866.
    PubMed     Abstract available
    
    
    
32. TRUONG TH, Benner EA, Hagen KM, Temiz NA, et al
    PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER(+) breast cancer.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01871.
    PubMed     Abstract available
    
    
    
33. NATHANSEN J, Lukiyanchuk V, Hein L, Stolte MI, et al
    Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
    Oncogene. 2021;40:4214-4228.
    PubMed     Abstract available
    
    
    May 2021
34. LAGER TW, Conner C, Keating CR, Warshaw JN, et al
    Cell surface GRP78 and Dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling.
    Oncogene. 2021 May 12. pii: 10.1038/s41388-021-01821.
    PubMed     Abstract available
    
    
    April 2021
35. ZHOU M, Zhang X, Liu C, Nie D, et al
    Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01799.
    PubMed     Abstract available
    
    
    
36. HAO T, Zhang C, Wang Z, Buck A, et al
    An aging mouse model of human chronic myeloid leukemia.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01770.
    PubMed     Abstract available
    
    
    March 2021
37. WANG YH, Chan YT, Hung TH, Hung JT, et al
    Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01729.
    PubMed     Abstract available
    
    
    
38. FUKASAWA K, Kadota T, Horie T, Tokumura K, et al
    CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
    Oncogene. 2021 Mar 16. pii: 10.1038/s41388-021-01745.
    PubMed     Abstract available
    
    
    
39. LEE HC, Ou CH, Huang YC, Hou PC, et al
    YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer.
    Oncogene. 2021 Mar 4. pii: 10.1038/s41388-021-01718.
    PubMed     Abstract available
    
    
    
40. KERR C, Szmacinski H, Fisher ML, Nance B, et al
    Correction to: Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.
    Oncogene. 2021 Mar 3. pii: 10.1038/s41388-021-01709.
    PubMed    
    
    
    
41. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
    Correction: TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Oncogene. 2021 Mar 2. pii: 10.1038/s41388-020-01620.
    PubMed    
    
    
    
42. WANG M, Zhao X, Qiu R, Gong Z, et al
    Lymph node metastasis-derived gastric cancer cells educate bone marrow-derived mesenchymal stem cells via YAP signaling activation by exosomal Wnt5a.
    Oncogene. 2021 Mar 2. pii: 10.1038/s41388-021-01722.
    PubMed     Abstract available
    
    
    
43. BIE Q, Song H, Chen X, Yang X, et al
    IL-17B/IL-17RB signaling cascade contributes to self-renewal and tumorigenesis of cancer stem cells by regulating Beclin-1 ubiquitination.
    Oncogene. 2021 Mar 1. pii: 10.1038/s41388-021-01699.
    PubMed     Abstract available
    
    
    February 2021
44. KIM JY, Kim HJ, Jung CW, Choi BI, et al
    Correction: PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
    Oncogene. 2021 Feb 8. pii: 10.1038/s41388-021-01644.
    PubMed    
    
    
    
45. LU J, Bang H, Kim SM, Cho SJ, et al
    Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.
    Oncogene. 2021;40:922-936.
    PubMed     Abstract available
    
    
    January 2021
46. ZHU P, He F, Hou Y, Tu G, et al
    A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.
    Oncogene. 2021 Jan 19. pii: 10.1038/s41388-020-01638.
    PubMed     Abstract available
    
    
    
47. BAI J, Yokomizo-Nakano T, Kubota S, Sun Y, et al
    Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01629.
    PubMed     Abstract available
    
    
    
48. KIM HJ, Kim JY, Jung CW, Lee YS, et al
    ANO1 regulates the maintenance of stemness in glioblastoma stem cells by stabilizing EGFRvIII.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01612.
    PubMed     Abstract available
    
    
    
49. KAUSHIK G, Seshacharyulu P, Rauth S, Nallasamy P, et al
    Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis.
    Oncogene. 2021;40:848-862.
    PubMed     Abstract available
    
    
    
50. LIN WH, Chang YW, Hong MX, Hsu TC, et al
    STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.
    Oncogene. 2021;40:791-805.
    PubMed     Abstract available
    
    
    December 2020
51. BERGIN CJ, Zouggar A, Haebe JR, Masibag AN, et al
    G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
    Oncogene. 2020 Dec 15. pii: 10.1038/s41388-020-01591.
    PubMed     Abstract available
    
    
    
52. HAN J, Qu H, Han M, Ding Y, et al
    MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
    Oncogene. 2020 Dec 3. pii: 10.1038/s41388-020-01574.
    PubMed     Abstract available
    
    
    November 2020
53. SARI IN, Yang YG, Wijaya YT, Jun N, et al
    AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth.
    Oncogene. 2020 Nov 17. pii: 10.1038/s41388-020-01547.
    PubMed     Abstract available
    
    
    
54. KIM JY, Kim HJ, Jung CW, Choi BI, et al
    PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
    Oncogene. 2020 Nov 13. pii: 10.1038/s41388-020-01543.
    PubMed     Abstract available
    
    
    October 2020
55. JIA Y, Ding X, Zhou L, Zhang L, et al
    Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
    Oncogene. 2020 Oct 29. pii: 10.1038/s41388-020-01486.
    PubMed     Abstract available
    
    
    
56. YOSHIDA A, Choi J, Jin HR, Li Y, et al
    Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3.
    Oncogene. 2020 Oct 29. pii: 10.1038/s41388-020-01532.
    PubMed     Abstract available
    
    
    
57. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    PubMed     Abstract available
    
    
    
58. ANGEL I, Pilo Kerman O, Rousso-Noori L, Friedmann-Morvinski D, et al
    Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma.
    Oncogene. 2020 Oct 19. pii: 10.1038/s41388-020-01506.
    PubMed     Abstract available
    
    
    
59. UKAI S, Honma R, Sakamoto N, Yamamoto Y, et al
    Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell.
    Oncogene. 2020 Oct 12. pii: 10.1038/s41388-020-01492.
    PubMed     Abstract available
    
    
    
60. LATTIER JM, De A, Chen Z, Morales JE, et al
    Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment.
    Oncogene. 2020 Oct 10. pii: 10.1038/s41388-020-01503.
    PubMed     Abstract available
    
    
    
61. CHU Y, Chen Y, Guo H, Li M, et al
    SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01495.
    PubMed     Abstract available
    
    
    
62. CHEN Y, Xu L, Lin RY, Muschen M, et al
    Core transcriptional regulatory circuitries in cancer.
    Oncogene. 2020;39:6633-6646.
    PubMed     Abstract available
    
    
    September 2020
63. KARRA L, Romero-Moya D, Ksionda O, Krush M, et al
    Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01469.
    PubMed     Abstract available
    
    
    
64. GAN T, Stevens AT, Xiong X, Wen YA, et al
    Inhibition of protein tyrosine phosphatase receptor type F suppresses Wnt signaling in colorectal cancer.
    Oncogene. 2020 Sep 24. pii: 10.1038/s41388-020-01472.
    PubMed     Abstract available
    
    
    July 2020
65. BUSCHHAUS JM, Humphries BA, Eckley SS, Robison TH, et al
    Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow.
    Oncogene. 2020 Jul 16. pii: 10.1038/s41388-020-01391.
    PubMed     Abstract available
    
    
    
66. CHAI TF, Manu KA, Casey PJ, Wang M, et al
    Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
    Oncogene. 2020;39:5373-5389.
    PubMed     Abstract available
    
    
    May 2020
67. SIMOES BM, Santiago-Gomez A, Chiodo C, Moreira T, et al
    Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer.
    Oncogene. 2020 May 30. pii: 10.1038/s41388-020-1335.
    PubMed     Abstract available
    
    
    
68. SIMON T, Jackson E, Giamas G
    Breaking through the glioblastoma micro-environment via extracellular vesicles.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1308.
    PubMed     Abstract available
    
    
    
69. CAVE DD, Di Guida M, Costa V, Sevillano M, et al
    TGF-beta1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation.
    Oncogene. 2020;39:4271-4285.
    PubMed     Abstract available
    
    
    
70. LARTIGUE L, Merle C, Lagarde P, Delespaul L, et al
    Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread.
    Oncogene. 2020;39:4198-4211.
    PubMed     Abstract available
    
    
    
71. MANJILI MH
    The premise of personalized immunotherapy for cancer dormancy.
    Oncogene. 2020;39:4323-4330.
    PubMed     Abstract available
    
    
    April 2020
72. YIN H, Jiang Z, Feng X, Ji Z, et al
    Identification of Sca-1(+)Abcg1(+) bronchioalveolar epithelial cells as the origin of lung adenocarcinoma in Gprc5a-knockout mouse model through the interaction between lung progenitor AT2 and Lgr5 cells.
    Oncogene. 2020;39:3754-3773.
    PubMed     Abstract available
    
    
    
73. REDONDO MONTE E, Wilding A, Leubolt G, Kerbs P, et al
    ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
    Oncogene. 2020;39:3195-3205.
    PubMed     Abstract available
    
    
    January 2020
74. RICCI B, Millner TO, Pomella N, Zhang X, et al
    Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1161.
    PubMed     Abstract available
    
    
    
75. MCGINN O, Ward AV, Fettig LM, Riley D, et al
    Cytokeratin 5 alters beta-catenin dynamics in breast cancer cells.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1164.
    PubMed     Abstract available
    
    
    November 2019
76. DONG KS, Chen Y, Yang G, Liao ZB, et al
    TGF-beta1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1107.
    PubMed     Abstract available
    
    
    
77. CHEN L, De Menna M, Groenewoud A, Thalmann GN, et al
    A NF-kB-Activin A signaling axis enhances prostate cancer metastasis.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1103.
    PubMed     Abstract available
    
    
    October 2019
78. KOUZI F, Zibara K, Bourgeais J, Picou F, et al
    Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Oncogene. 2019 Oct 24. pii: 10.1038/s41388-019-1069.
    PubMed     Abstract available
    
    
    
79. VESCHI V, Mangiapane LR, Nicotra A, Di Franco S, et al
    Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1047.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: